145 related articles for article (PubMed ID: 33023494)
1. Thrombolysis implementation intervention and clinical outcome: a secondary analysis of a cluster randomized trial.
Hasnain MG; Paul CL; Attia JR; Ryan A; Kerr E; Oldmeadow C; D'Este CA; Bivard A; Hubbard IJ; Milton AH; Levi CR
BMC Cardiovasc Disord; 2020 Oct; 20(1):432. PubMed ID: 33023494
[TBL] [Abstract][Full Text] [Related]
2. Cluster-Randomized Trial of Thrombolysis Implementation Support in Metropolitan and Regional Australian Stroke Centers: Lessons for Individual and Systems Behavior Change.
Levi CR; Attia JA; D'Este C; Ryan AE; Henskens F; Kerr E; Parsons MW; Sanson-Fisher RW; Bladin CF; Lindley RI; Middleton S; Paul CL; ;
J Am Heart Assoc; 2020 Feb; 9(3):e012732. PubMed ID: 31973599
[TBL] [Abstract][Full Text] [Related]
3. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
Dong Y; Han Y; Shen H; Wang Y; Ma F; Li H; Wang Y; Dong Q
Stroke Vasc Neurol; 2020 Dec; 5(4):348-352. PubMed ID: 32611728
[TBL] [Abstract][Full Text] [Related]
4. Elevated Levels of Inflammation Markers Predict Poor Outcomes in Acute Ischemic Stroke Patients After Intravenous Thrombolysis.
Hu D; Ding C; Jiang X; Xiao J; Li C; Zhang L; Li T; Ji Y; Peng Y; Luo X; Sheng L; Wang Q; Wu H
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105587. PubMed ID: 33450606
[TBL] [Abstract][Full Text] [Related]
5. Door-to-needle time for thrombolysis: a secondary analysis of the TIPS cluster randomised controlled trial.
Hasnain MG; Paul CL; Attia JR; Ryan A; Kerr E; D'Este C; Hall A; Milton AH; Hubbard IJ; Levi CR
BMJ Open; 2019 Dec; 9(12):e032482. PubMed ID: 31843839
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.
You S; Saxena A; Wang X; Tan W; Han Q; Cao Y; Liu CF
Stroke Vasc Neurol; 2018 Mar; 3(1):22-27. PubMed ID: 29600004
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Homeless Ischemic Stroke Patients Receiving Intravenous Thrombolysis in the United States.
Asaithambi G; Marino EH; Ho BM; Tipps ME
J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105862. PubMed ID: 34034124
[TBL] [Abstract][Full Text] [Related]
8. Insulin Resistance is Significantly Related with Worse Clinical Outcomes in Non-Diabetic Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
Yang X; Li C; Li J; Hou D; Luo Y; Zhang S; Jin Z; Shen L; Zhong P; Wu D
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105526. PubMed ID: 33338704
[TBL] [Abstract][Full Text] [Related]
9. Telemedical Brain Computed Tomography Misinterpretation by Stroke Neurologists Is Not Associated with Thrombolysis-Related Intracranial Hemorrhage.
Zerna C; von Kummer R; Gerber J; Engellandt K; Abramyuk A; Wojciechowski C; Barlinn K; Kepplinger J; Pallesen LP; Siepmann T; Dzialowski I; Reichmann H; Puetz V; Bodechtel U
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1520-6. PubMed ID: 25873473
[TBL] [Abstract][Full Text] [Related]
10. White Matter Hypoperfusion Associated with Leukoaraiosis Predicts Intracranial Hemorrhage after Intravenous Thrombolysis.
Qiu F; Chen C; Fan Z; Qiu J; Chen Q; Shao B
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105528. PubMed ID: 33307291
[TBL] [Abstract][Full Text] [Related]
11. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial.
Song L; Wang X; Robinson T; Lindley RI; Arima H; Lavados PM; Chen X; Chalmers J; Anderson CS
Stroke Vasc Neurol; 2017 Jun; 2(2):53-58. PubMed ID: 28959492
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
Yeo LL; Kong WY; Paliwal P; Teoh HL; Seet RC; Soon D; Rathakrishnan R; Ong V; Lee TH; Wong HF; Chan BP; Leow WK; Yuan C; Ting E; Gopinathan A; Tan BY; Sharma VK
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361
[TBL] [Abstract][Full Text] [Related]
14. Does Body Mass Index Impact the Outcome of Stroke Patients Who Received Intravenous Thrombolysis?
Zambrano Espinoza MD; Lail NS; Vaughn CB; Shirani P; Sawyer RN; Mowla A
Cerebrovasc Dis; 2021; 50(2):141-146. PubMed ID: 33423033
[TBL] [Abstract][Full Text] [Related]
15. Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries.
Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e007150. PubMed ID: 33302714
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Intravenous Thrombolytic Therapy in Patients With Acute Posterior Circulation Stroke: A Single-Center Study.
Zhu X; Wang N; Lin H; Zhang P; Chen L; Zhang M; Deng B; Wu T
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104537. PubMed ID: 31806454
[TBL] [Abstract][Full Text] [Related]
17. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
18. Mean Platelet Volume is a Prognostic Marker in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
Dourado Sotero F; Calçada A; Aguiar de Sousa D; Dias M; Fonseca AC; Pinho E Melo T; Canhão P
J Stroke Cerebrovasc Dis; 2021 Jun; 30(6):105718. PubMed ID: 33838517
[TBL] [Abstract][Full Text] [Related]
19. Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients?
Chen S; Lu X; Zhang W; Han Z; Yang W; Huang X; Jin X; Wang Z; Liang H; Qiu W; Cheng J; Shao B
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1366-70. PubMed ID: 26996750
[TBL] [Abstract][Full Text] [Related]
20. Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.
Wang X; You S; Sato S; Yang J; Carcel C; Zheng D; Yoshimura S; Anderson CS; Sandset EC; Robinson T; Chalmers J; Sharma VK
Stroke Vasc Neurol; 2018 Mar; 3(1):28-33. PubMed ID: 29600005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
